AGÕæÈ˹ٷ½

STOCK TITAN

Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Sona Nanotech (OTCQB:SNANF)(CSE:SONA) has announced that CEO David Regan will deliver a presentation at the upcoming Investor Summit Virtual event. The presentation is scheduled for March 11th at 11:30am ET.

Sona Nanotech (OTCQB:SNANF)(CSE:SONA) ha annunciato che il CEO David Regan terrà una presentazione all'imminente evento Investor Summit Virtual. La presentazione è programmata per l'11 marzo alle 11:30 ET.

Sona Nanotech (OTCQB:SNANF)(CSE:SONA) ha anunciado que el CEO David Regan realizará una presentación en el próximo evento Investor Summit Virtual. La presentación está programada para el 11 de marzo a las 11:30 a.m. ET.

Sona Nanotech (OTCQB:SNANF)(CSE:SONA)ëŠ� CEO David Reganì� 다가오는 Investor Summit Virtual 행사ì—서 발표ë¥� í•� 것ì´ë¼ê³  발표했습니다. 발표ëŠ� 3ì›� 11ì� 오전 11ì‹� 30ë¶� ETë¡� 예정ë˜ì–´ 있습니다.

Sona Nanotech (OTCQB:SNANF)(CSE:SONA) a annoncé que le PDG David Regan fera une présentation lors du prochain événement Investor Summit Virtual. La présentation est prévue pour le 11 mars à 11h30 ET.

Sona Nanotech (OTCQB:SNANF)(CSE:SONA) hat angekündigt, dass CEO David Regan eine Präsentation auf der bevorstehenden Veranstaltung Investor Summit Virtual halten wird. Die Präsentation ist für den 11. März um 11:30 Uhr ET angesetzt.

Positive
  • None.
Negative
  • None.

NEW YORK, NY / / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.

About Sona Nanotech Inc.(OTCQB: SNANF) (CSE: SONA),

Sona Nanotech Inc. has developed a novel cancer immunotherapy and is on the cusp of human trials. Its ‘Targeted Hyperthermia Therapy' (THT) has demonstrated preclinical efficacy in the elimination of both primary tumors as well as distant, untreated metastases where standard immunotherapies have not worked. Sona's THT heats tumors from the inside out using its proprietary gold nanorods, killing cancer cells and triggering a systemic immune response that can also eliminate untreated, distant metastases.

Event: Q1 Investor Summit
Presentation Time:11:30 AM ET
Location:

Conference Overview and Structure

The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.

This quarter's event is focused on MicroCap"/articles/market-capitalization-explained" title="Read: What Is Market Capitalization and How It Is Calculated" class="article-link" rel="noopener">MicroCap companies who are undervalued, have a catalyst, and are undervalued.

Registration for Investors

To request free registration, please go to our website (), and click the "Registration" button.

Sponsors:

  • Access Newswire

  • PCG Advisory

  • QuoteMedia

  • AGP

  • MZ Group

News Compliments of

For More Information

Please visit:
Or, contact [email protected]

SOURCE: Sona Nanotech Inc.



View the original on ACCESS Newswire

FAQ

When is Sona Nanotech (SNANF) presenting at the Investor Summit Virtual 2025?

Sona Nanotech (SNANF) will present on March 11, 2025, at 11:30am ET.

Who will represent SNANF at the 2025 Investor Summit Virtual?

David Regan, CEO of Sona Nanotech, will present at the event.

On which exchanges is Sona Nanotech (SNANF) listed?

Sona Nanotech trades on OTCQB under SNANF and on CSE under SONA.

What type of event is the Investor Summit where SNANF is presenting?

The Investor Summit is a virtual investment conference where companies present to investors.
Sona Nanotech

OTC:SNANF

SNANF Rankings

SNANF Latest News

SNANF Stock Data

47.72M
89.79M
19.39%
Diagnostics & Research
Healthcare
Canada
Halifax